Centro Nacional de Epidemiología-ko ikertzaileekin lankidetzan egindako argitalpenak (31)

2023

  1. Seizure prophylaxis in meningiomas: A systematic review and meta-analysis

    Neurologia, Vol. 38, Núm. 4, pp. 291-302

2021

  1. Feasibility of a screening program for the detection of intracranial meningiomas

    Revista Espanola de Salud Publica, Vol. 95

  2. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

    BMC Neurology, Vol. 21, Núm. 1

2020

  1. A Practical Overview on the Molecular Biology of Meningioma

    Current Neurology and Neuroscience Reports, Vol. 20, Núm. 12

  2. Active commuting, physical activity, and sedentary behaviors in children and adolescents from spain: Findings from the ANIBES study

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 2

  3. Effects of Motor Symptom Laterality on Clinical Manifestations and Quality of Life in Parkinson's Disease

    Journal of Parkinson's Disease, Vol. 10, Núm. 4, pp. 1611-1620

  4. Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort

    Scientific Reports, Vol. 10, Núm. 1

  5. The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype

    Neurological Sciences, Vol. 41, Núm. 10, pp. 2883-2892

2019

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

    European Journal of Neurology, Vol. 26, Núm. 11, pp. 1399-1407

  2. High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson’s disease patients

    Journal of Neural Transmission, Vol. 126, Núm. 12, pp. 1599-1608

  3. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

    Parkinsonism and Related Disorders, Vol. 66, pp. 151-157

2018

  1. Improvement of impulse control disorders associated with levodopa–carbidopa intestinal gel treatment in advanced Parkinson’s disease

    Journal of Neurology, Vol. 265, Núm. 6, pp. 1279-1287

  2. Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations

    Movement Disorders Clinical Practice, Vol. 5, Núm. 4, pp. 361-372

  3. Rating scales for cognition in Huntington's disease: Critique and recommendations

    Movement Disorders, Vol. 33, Núm. 2, pp. 187-195

2017

  1. Response to letter by Saenz-Farret et al. on “Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations”

    Movement Disorders

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

  2. Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression [BMC Neurol. 16, (2015), 26] DOI: 10.1186/s12883-016-0548-9

    BMC Neurology

  3. Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

    Movement Disorders Clinical Practice, Vol. 3, Núm. 6, pp. 527-537

  4. Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations

    Movement Disorders, Vol. 31, Núm. 10, pp. 1466-1478

2015

  1. Parkinson symptoms and health related quality of life as predictors of costs: A longitudinal observational study with linear mixed model analysis

    PLoS ONE, Vol. 10, Núm. 12